Stay updated on Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe revision label on the page has been updated from v3.5.3 to v3.5.4, indicating a backend/site update rather than a change to the study data.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe ClinicalTrials.gov page revision label was updated from **v3.5.2** to **v3.5.3**, indicating a website/platform release rather than a change to the study information.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3 tag.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to study details or user-facing content.SummaryDifference0.1%

- Check107 days agoChange DetectedRevision: v3.4.2 was added and the government funding notice along with Revision: v3.4.1 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.